← REGULATORY CHANGES
FEDERAL REGISTER · RULESeptember 20, 2024IN FORCE

Regulatory Hearing Before the Food and Drug Administration; General Provisions; Amendments

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSIN FORCE
EFFECTIVEFeb 3, 2025
COMMENTS CLOSEDec 4, 2024 · closed
APPLIES TO · SPEQ TAGNot tagged
Document type
Rule
Agency
Health and Human Services Department
Published
September 20, 2024
Effective
February 3, 2025
Comments close
December 4, 2024
Document number
2024-21231
CFR references
21 CFR 16
Docket
FDA-2024-N-3654
RIN
0910-AI97
ABSTRACT

The Food and Drug Administration (FDA, Agency, or we) is issuing a direct final rule amending the Scope section of our regulation that provides for a regulatory hearing before the Agency in order to clarify when such hearings are available. We are revising the list of statutory provisions enumerated in the Scope section of the regulation by adding one statutory reference and removing a different statutory reference. The Agency is issuing these amendments directly as a final rule because we believe they are noncontroversial and FDA anticipates no significant adverse comments.

Abstract as published in the Federal Register.

READ THE FULL DOCUMENT

The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.

View on federalregister.gov →

That is what FDA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.

Create a free account